🧬Rare & Orphan Diseases
Market Cap$335.6B
1D-1.59%
Companies239
Public Cos59
SECTOR MARKET CAP
$335.6B+298.3%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Japan | $56.3B | TAK |
| 2 |  | United States | $29.3B | INSM |
| 3 |  | United States | $23.0B | UTHR |
| 4 |  | United Kingdom | $19.8B | ROIV |
| 5 |  | France | $14.2B | IPN.PA |
| 6 |  | Denmark | $13.6B | ASND |
| 7 |  | Sweden | $13.3B | SOBI.ST |
| 8 |  | United States | $13.3B | BBIO |
| 9 |  | United States | $11.7B | IONS |
| 10 |  | Ireland | $11.1B | JAZZ |
| 11 |  | Italy | $10.5B | REC.MI |
| 12 |  | United States | $10.4B | BMRN |
| 13 |  | United States | $8.3B | PRAX |
| 14 |  | United States | $7.9B | ARWR |
| 15 |  | Japan | $7.7B | 4151.T |
| 16 |  | Taiwan | $7.4B | 6446.TW |
| 17 |  | United States | $7.4B | KRYS |
| 18 |  | United States | $6.1B | BLTE |
| 19 |  | United States | $6.0B | RYTM |
| 20 |  | United States | $5.4B | COGT |